AstraZeneca seeks emergency U.S. approval of new drug to prevent COVID-19

Infectious diseases specialist Dr. Isaac Bogoch explains the potential impact of AstraZeneca's new COVID-19 antibody therapy. He's waiting to see if recent favourable data stands up over time.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting